Mylan’s Generic Version of Biogen’s MS Drug Gets FDA Approval Post author:Sam Post published:August 20, 2020 Post category:Devices & Diagnostics Letter Mylan has launched the product in 120mg and 240mg delayed-release capsule forms. Source: Devices & Diagnostics Letter You Might Also Like FDA Approves Sanofi’s Meningococcal Vaccine April 23, 2020 CDC Issues New Coronavirus Test Reagents February 24, 2020 Gilead Sciences Gears Up for Clinical Trials of Inhaled Remdesivir June 22, 2020